7Baggers
 Pleasing Signs As A Number Of Insiders Buy Arcus Biosciences Stock  simplywall.st Fri, 03 Oct 2025 10:05:35 GMT
 Published on: 2025-09-30 20:31:22  newser.com Wed, 01 Oct 2025 01:31:22 GMT
 Insider Sell: Alexander Azoy Sells Shares of Arcus Biosciences I  GuruFocus Wed, 01 Oct 2025 00:44:16 GMT
 Technical analysis overview for Arcus Biosciences Inc. stock  newser.com Mon, 29 Sep 2025 07:43:12 GMT
 published on: 2025-09-29 02:24:19  newser.com Mon, 29 Sep 2025 07:24:19 GMT
 Arcus Biosciences Scores Relative Strength Rating Upgrade; Hits Key Threshold  Investor's Business Daily Mon, 29 Sep 2025 07:00:00 GMT
 arcus biosciences announces new employment inducement grants  The Globe and Mail Wed, 24 Sep 2025 20:35:00 GMT
 Published on: 2025-09-16 14:51:47  خودرو بانک Tue, 16 Sep 2025 11:25:07 GMT
 arcus biosciences (nyse:rcus) stock price down 8% - here's why  MarketBeat Wed, 10 Sep 2025 19:22:22 GMT
 Arcus Biosciences at H.C. Wainwright: Strategic Moves in RCC Market  Investing.com Tue, 09 Sep 2025 07:00:00 GMT
 arcus biosciences inc (rcus) announces equity awards for new emp  GuruFocus Mon, 08 Sep 2025 21:15:16 GMT
 arcus biosciences announces new employment inducement grants  MarketScreener Mon, 08 Sep 2025 07:00:00 GMT
 published on: 2025-09-04 03:31:21  Newser Thu, 04 Sep 2025 08:31:21 GMT
 published on: 2025-09-03 23:12:29  Newser Thu, 04 Sep 2025 04:12:29 GMT
 published on: 2025-09-03 03:02:33  Newser Wed, 03 Sep 2025 08:02:33 GMT
 Arcus Biosciences at Citi’s Biopharma: Strategic Clinical Moves  Investing.com Wed, 03 Sep 2025 07:00:00 GMT
 published on: 2025-08-30 19:59:15  Newser Sun, 31 Aug 2025 00:59:15 GMT
 published on: 2025-08-30 18:25:49  Newser Sat, 30 Aug 2025 23:25:49 GMT
 published on: 2025-08-29 12:07:50  Newser Fri, 29 Aug 2025 17:07:50 GMT
 published on: 2025-08-29 00:58:30  Newser Fri, 29 Aug 2025 05:58:30 GMT
 published on: 2025-08-28 16:44:06  Newser Thu, 28 Aug 2025 21:44:06 GMT
 published on: 2025-08-28 14:29:30  Newser Thu, 28 Aug 2025 19:29:30 GMT
 Gilead and Arcus Biosciences Complete Promising Cancer Study  TipRanks Thu, 28 Aug 2025 07:00:00 GMT

Arcus Biosciences, Inc
(NYSE:RCUS) 

RCUS stock logo

Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 a...

Founded: 2015
Full Time Employees: 139
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends